LENZ
LENZ Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.85
+0.34%Margins
Gross margin
90.1%
EBITDA margin
-584.6%
EBIT margin
-631.7%
Net margin
-586.7%
FCF margin
-532.8%
-57.5%
Return on equity
-53.3%
Return on assets
-61.8%
Return on invested capital
0.08x
Asset turnover
-$113.9M
Cash from operations
$7.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026